Parallel neurodegenerative phenotypes in sporadic Parkinson's disease fibroblasts and midbrain dopamine neurons

被引:7
|
作者
Corenblum, M. J. [1 ]
McRobbie-Johnson, A. [2 ]
Carruth, E. [3 ]
Bernard, K. [2 ]
Luo, M. [4 ]
Mandarino, L. J. [4 ]
Peterson, S. [5 ]
Sans-Fuentes, M. A. [5 ]
Billheimer, D. [5 ]
Maley, T. [2 ]
Eggers, E. D. [6 ,7 ]
Madhavan, L. [1 ,8 ,9 ,10 ]
机构
[1] Univ Arizona, Dept Neurol, Tucson, AZ USA
[2] Univ Arizona, Physiol Sci Grad Program, Tucson, AZ USA
[3] Univ Arizona, Physiol Undergraduate Program, Tucson, AZ USA
[4] Univ Arizona, Dept Med, Tucson, AZ USA
[5] Univ Arizona, BIO5 Inst, Stat Consulting Lab, Tucson, AZ USA
[6] Univ Arizona, Dept Physiol, Tucson, AZ USA
[7] Univ Arizona, Dept Biomed Engn, Tucson, AZ USA
[8] Univ Arizona, Evelyn McKnight Brain Inst, Tucson, AZ USA
[9] Univ Arizona, BIO5 Inst, Tucson, AZ USA
[10] Univ Arizona, Dept Neurol, 1501,N Campbell Ave, Tucson, AZ 85724 USA
关键词
Skin fibroblasts; Human Induced Pluripotent Stem Cells; Midbrain Dopamine Neurons; Aging; Parkinson 's disease; Mitochondrial Dysfunction; ALPHA-SYNUCLEIN; HUMAN ES; CELLS; MITOCHONDRIA;
D O I
10.1016/j.pneurobio.2023.102501
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Understanding the mechanisms causing Parkinson's disease (PD) is vital to the development of much needed early diagnostics and therapeutics for this debilitating condition. Here, we report cellular and molecular alterations in skin fibroblasts of late-onset sporadic PD subjects, that were recapitulated in matched induced pluripotent stem cell (iPSC)-derived midbrain dopamine (DA) neurons, reprogrammed from the same fibroblasts. Specific changes in growth, morphology, reactive oxygen species levels, mitochondrial function, and autophagy, were seen in both the PD fibroblasts and DA neurons, as compared to their respective controls. Additionally, significant alterations in alpha synuclein expression and electrical activity were also noted in the PD DA neurons. Interestingly, although the fibroblast and neuronal phenotypes were similar to each other, they differed in their nature and scale. Furthermore, statistical analysis revealed potential novel associations between various clinical measures of the PD subjects and the different fibroblast and neuronal data. In essence, these findings encapsulate spontaneous, in-tandem, disease-related phenotypes in both sporadic PD fibroblasts and iPSC-based DA neurons, from the same patient, and generates an innovative model to investigate PD mechanisms with a view towards rational disease stratification and precision treatments.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] Does Developmental Variability in the Number of Midbrain Dopamine Neurons Affect Individual Risk for Sporadic Parkinson?s Disease?
    von Linstow, Christian U.
    DeLano-Taylor, Merritt
    Kordower, Jeffrey H.
    Brundin, Patrik
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (02) : 405 - 411
  • [2] Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease
    Sanchez-Danes, Adriana
    Richaud-Patin, Yvonne
    Carballo-Carbajal, Iria
    Jimenez-Delgado, Senda
    Caig, Carles
    Mora, Sergio
    Di Guglielmo, Claudia
    Ezquerra, Mario
    Patel, Bindiben
    Giralt, Albert
    Canals, Josep M.
    Memo, Maurizio
    Alberch, Jordi
    Lopez-Barneo, Jose
    Vila, Miquel
    Maria Cuervo, Ana
    Tolosa, Eduard
    Consiglio, Antonella
    Raya, Angel
    EMBO MOLECULAR MEDICINE, 2012, 4 (05) : 380 - 395
  • [3] Organization of midbrain dopamine systems and the pathophysiology of Parkinson's disease
    Moore, RY
    PARKINSONISM & RELATED DISORDERS, 2003, 9 : S65 - S71
  • [4] Midbrain dopamine neurons in Parkinson's disease exhibit a dysregulated miRNA and target-gene network
    Briggs, Christine E.
    Wang, Yulei
    Kong, Benjamin
    Woo, Tsung-Ung W.
    Iyer, Lakshmanan K.
    Sonntag, Kai C.
    BRAIN RESEARCH, 2015, 1618 : 111 - 121
  • [5] THE PROFILE OF CSF NEURODEGENERATIVE MARKERS IN DIFFERENT PHENOTYPES OF PARKINSON'S DISEASE
    Vranova, H. Prikrylova
    Mares, J.
    Hlustik, P.
    Nevrly, M.
    Stejskal, D.
    Zapletalova, J.
    Obereigneru, R.
    Kanovsky, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 236 - 236
  • [6] Subtype selective loss of homeostatic activity control in dopamine midbrain neurons in early Parkinson Disease
    Roeper, J.
    Subramaniam, M.
    ACTA PHYSIOLOGICA, 2015, 213 : 32 - 32
  • [7] Heterogeneity of the midbrain dopamine system Implications for Parkinson disease
    Hassan, Anhar
    Benarroch, Eduardo E.
    NEUROLOGY, 2015, 85 (20) : 1795 - 1805
  • [9] Cell death of dopamine neurons in aging and Parkinson's disease
    Naoi, M
    Maruyama, W
    MECHANISMS OF AGEING AND DEVELOPMENT, 1999, 111 (2-3) : 175 - 188
  • [10] BAX protein-immunoreactivity in midbrain neurons of Parkinson's disease patients
    Horowitz, JM
    Pastor, DM
    Goyal, A
    Kar, S
    Ramdeen, N
    Hallas, BH
    Torres, G
    BRAIN RESEARCH BULLETIN, 2003, 62 (01) : 55 - 61